We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$10.8B
AUM Growth
-$4.51B
Cap. Flow
-$5.9B
Cap. Flow %
-54.51%
Top 10 Hldgs %
36.37%
Holding
2,157
New
513
Increased
320
Reduced
516
Closed
607

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$126M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$56.9M
3
ARGX icon
argenx
ARGX
+$51.2M
4
DAL icon
Delta Air Lines
DAL
+$47.9M
5
GLNG icon
Golar LNG
GLNG
+$41.7M

Sector Composition

Rank Sector Weight
1 Healthcare 8.36%
2 Technology 4.71%
3 Industrials 4.28%
4 Financials 3.27%
5 Energy 3.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFMD icon
1301
LifeMD
LFMD
$176M
$125K ﹤0.01%
+12,200
New +$90.2K
MAMA icon
1302
Mama's Creations
MAMA
$849M
$124K ﹤0.01%
24,800
+3,400
+16% +$16.1K
QVCGA
1303
DELISTED
QVC Group Inc Series A
QVCGA
$123K ﹤0.01%
+2,000
New +$105K
KWEB icon
1304
KraneShares CSI China Internet ETF
KWEB
$5.55B
$120K ﹤0.01%
4,576
-129,654
-97% -$3.27M
SMXT icon
1305
Solarmax Technology
SMXT
$21.5M
$120K ﹤0.01%
+13,100
New +$95.8K
RAPT
1306
DELISTED
RAPT Therapeutics
RAPT
$118K ﹤0.01%
1,649
PLTK icon
1307
Playtika
PLTK
$1.51B
$118K ﹤0.01%
+16,767
New +$124K
AEHR icon
1308
PUT
Aehr Test Systems
AEHR
$2.51B
$118K ﹤0.01%
+9,500
New +$158K
CBIO
1309
Crescent Biopharma
CBIO
$555M
$115K ﹤0.01%
+382
New +$114K
REKR icon
1310
Rekor Systems
REKR
$84.6M
$114K ﹤0.01%
49,800
+2,600
+6% +$7.17K
S icon
1311
SentinelOne
S
$6.31B
$114K ﹤0.01%
4,872
-3,028
-38% -$79.1K
AIP icon
1312
Arteris
AIP
$1.35B
$113K ﹤0.01%
+15,500
New +$99.9K
BVS icon
1313
Bioventus
BVS
$893M
$113K ﹤0.01%
+21,700
New +$106K
NNBR icon
1314
NN Inc
NNBR
$257M
$113K ﹤0.01%
+23,800
New +$109K
MFIN icon
1315
Medallion Financial
MFIN
$233M
$112K ﹤0.01%
14,100
+100
+0.7% +$899
LXP icon
1316
LXP Industrial Trust
LXP
$3.58B
$111K ﹤0.01%
+2,467
New +$112K
NUVB icon
1317
Nuvation Bio
NUVB
$2.33B
$109K ﹤0.01%
+30,000
New +$57.6K
BTSG icon
1318
BrightSpring Health Services
BTSG
$14.3B
$109K ﹤0.01%
+10,000
New +$100K
KNTE
1319
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$108K ﹤0.01%
40,500
ECHO
1320
CALL
EchoStar
ECHO
$25B
$107K ﹤0.01%
+7,500
New +$105K
OPTU
1321
Optimum Communications Inc
OPTU
$290M
$104K ﹤0.01%
40,000
-47,562
-54% -$120K
ESPR
1322
PUT
DELISTED
Esperion Therapeutics
ESPR
$104K ﹤0.01%
+38,700
New +$94K
MRAM icon
1323
Everspin Technologies
MRAM
$339M
$102K ﹤0.01%
12,900
+400
+3% +$3.41K
AXTI icon
1324
AXT Inc
AXTI
$3.07B
$102K ﹤0.01%
+22,200
New +$75.4K
ALIM
1325
DELISTED
Alimera Sciences
ALIM
$102K ﹤0.01%
26,100
+13,200
+102% +$50.2K

Similar funds

Jefferies Financial Group's Q1 2024 Portfolio in Review

As of Q1 2024, Jefferies Financial Group held 2,157 positions worth $10.8B, down 29% from $15.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Jefferies Financial Group withdrew a net $5.9B in Q1 2024, closing 607 positions and reducing 516 holdings. Its most notable exit was Surgery Partners, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, up from 6.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Jefferies Financial Group opened a new position in Golar LNG worth $45M.

  • Jefferies Financial Group's largest Q1 2024 buy was Golar LNG: 1,872,202 shares worth $45M.
  • Jefferies Financial Group added most to Visa in Q1 2024, an estimated $126M increase.
  • Jefferies Financial Group's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $962M.
  • Jefferies Financial Group fully exited Surgery Partners in Q1 2024, selling an estimated $146M.
  • Jefferies Financial Group's ten largest holdings make up 36% of its $10.8B portfolio in Q1 2024.
  • Jefferies Financial Group opened 513 new positions and closed 607 in Q1 2024.
  • Jefferies Financial Group's portfolio value fell 29% quarter-over-quarter to $10.8B.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.